Some sulfonylureas increase risk of MACE in patients with T2DM

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1899卷 / 1期

关键词：

D O I：

10.1007/s40278-022-11985-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[1] Psoriasis might increase risk of T2DM
[J]. Nature Reviews Endocrinology, 2012, 8 (9) : 508 - 508
[2] Risk of cardiovascular disease in patients with T2DM
[J]. Nature Reviews Endocrinology, 2013, 9 (6) : 316 - 316
[3] Intensive treatment of T2DM may increase hypoglycaemia risk
[J]. Reactions Weekly, 2016, 1607 (1) : 10 - 10
[4] Current lifestyle factors that increase risk of T2DM in China
N Zhang
S M Du
G S Ma
[J]. European Journal of Clinical Nutrition, 2017, 71 : 832 - 838
[5] Current lifestyle factors that increase risk of T2DM in China
Zhang, N.
Du, S. M.
Ma, G. S.
[J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2017, 71 (07) : 832 - 838
[6] SGLT-2 inhibitors increase risk of amputation in T2DM
[J]. Reactions Weekly, 2018, 1717 (1) : 12 - 12
[7] GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA
Monti, C., I
[J]. VALUE IN HEALTH, 2017, 20 (09) : A919 - A919
[8] Evaluation of some Inflammatory Markers Enzymes in T2DM Patients
Mahmoud, Mohammed Wisam
Khalid, Zaidan Noor
Hiba, Al-Hadithe
[J]. RESEARCH JOURNAL OF BIOTECHNOLOGY, 2024, 19 (08):
[9] Defining genetic risk of T2DM
Claire Greenhill
[J]. Nature Reviews Endocrinology, 2019, 15 : 438 - 438
[10] Defining genetic risk of T2DM
Greenhill, Claire
[J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (08) : 438 - 438

← 1 2 3 4 5 →